Patents by Inventor Julian Grigg

Julian Grigg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9523778
    Abstract: The present invention relates to calibration and normalization systems and methods for ensuring the quality of radiopharmaceuticals during the synthesis thereof, such as radiopharmaceuticals used in Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT).
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: December 20, 2016
    Inventors: Torgrim Engell, Julian Grigg
  • Publication number: 20160314866
    Abstract: The present invention relates to methods and devices for evacuating the contents of a primary waste vessel to a secondary waste vessel, desirably between production runs of an automated synthesis device.
    Type: Application
    Filed: December 19, 2014
    Publication date: October 27, 2016
    Inventors: Nigel John Osborn, Julian Grigg, Eric Horn, Jonathan Robert Shales
  • Publication number: 20160303260
    Abstract: The present invention relates to improved 18F-labelled aldehyde compositions, wherein impurities which affect imaging in vivo are identified and suppressed. Also provided are methods of preparation of radiofluorinated biological targeting molecules using said improved compositions, together with radiopharmaceutical compositions. The invention also includes methods of imaging and/or diagnosis using the radiopharmaceutical compositions described.
    Type: Application
    Filed: November 25, 2013
    Publication date: October 20, 2016
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Torgrim Engell, Julian Grigg
  • Publication number: 20160022847
    Abstract: The present invention relates to improved radiotracer imaging agent compositions, which comprises 18F-labelled biological targeting moieties, wherein impurities which affect imaging in vivo are identified and suppressed. Also provided are radiopharmaceuticals comprising said improved compositions, together with radiofluorinated aldehyde compositions useful in preparing said radiotracer compositions. The invention also includes methods of imaging and/or diagnosis using the radiopharmaceutical compositions described.
    Type: Application
    Filed: October 7, 2015
    Publication date: January 28, 2016
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Torgrim Engell, Julian Grigg, Dimitrios Mantzilas
  • Patent number: 9180213
    Abstract: The present invention relates to improved radiotracer imaging agent compositions, which comprises 18F-labelled biological targeting moieties, wherein impurities which affect imaging in vivo are identified and suppressed. Also provided are radiopharmaceuticals comprising said improved compositions, together with radiofluorinated aldehyde compositions useful in preparing said radiotracer compositions. The invention also includes methods of imaging and/or diagnosis using the radiopharmaceutical compositions described.
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: November 10, 2015
    Assignee: GE Healthcare Limited
    Inventors: Torgrim Engell, Julian Grigg, Dimitrios Mantzilas
  • Publication number: 20150139902
    Abstract: The present invention relates to a method of purification of [18F]-fluciclatide via solid phase extraction (SPE). The method is amenable to automation, and is suitable for use in conjunction with automated synthesizer apparatus—especially cassette-based synthesizers. Also provided are cassettes for carrying out the purification method.
    Type: Application
    Filed: May 23, 2013
    Publication date: May 21, 2015
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Torgrim Engell, Dimitrios Mantzilas, Julian Grigg
  • Publication number: 20150018541
    Abstract: The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-?-D-mannopyranose which are used as precursors for production of radiofluoridated sugar derivatives for use in in vivo imaging procedures such as positron emission tomography (PET). The method comprises storing the non fluoridated sugar derivative in an organic solvent. The resultant formulations of the non fluoridated sugar derivative and cassettes for automated synthesis apparatus comprising the same are also claimed.
    Type: Application
    Filed: April 22, 2014
    Publication date: January 15, 2015
    Applicants: GE HEALTHCARE AS, GE HEALTHCARE LIMITED
    Inventors: Torild WICKSTROM, DIRK-JAN IN'T VELD, NIGEL JOHN OSBORN, JULIAN GRIGG, ANTHONY WILSON
  • Publication number: 20140257566
    Abstract: The present invention relates to calibration and normalization systems and methods for ensuring the quality of radiopharmaceuticals during the synthesis thereof, such as radiopharmaceuticals used in Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT).
    Type: Application
    Filed: September 24, 2012
    Publication date: September 11, 2014
    Inventors: Torgrim Engell, Julian Grigg, Ingvil Gausemel, Knut Dyrstad, Jonathan R. Shales
  • Publication number: 20140243500
    Abstract: The present invention relates to calibration and normalization systems and methods for ensuring the quality of radiopharmaceuticals during the synthesis thereof, such as radiopharmaceuticals used in Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT).
    Type: Application
    Filed: September 28, 2012
    Publication date: August 28, 2014
    Inventors: Torgrim Engell, Julian Grigg
  • Publication number: 20130259804
    Abstract: The present invention relates to improved radiotracer imaging agent compositions, which comprises 18F-labelled biological targeting moieties, wherein impurities which affect imaging in vivo are identified and suppressed. Also provided are radiopharmaceuticals comprising said improved compositions, together with radiofluorinated aldehyde compositions useful in preparing said radiotracer compositions. The invention also includes methods of imaging and/or diagnosis using the radiopharmaceutical compositions described.
    Type: Application
    Filed: December 9, 2011
    Publication date: October 3, 2013
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Torgrim Engell, Julian Grigg, Dimtrios Mantzilas
  • Patent number: 8053622
    Abstract: The invention describes a method for stripping alumina which is particularly suitable for removal of fluoride from alumina and comprises washing said alumina with an aqueous acid or alkali at elevated temperature. The method may be used for removal of unreacted radiofluoride such as [18F]fluoride from alumina following a radiofluorination reaction. Automated synthesis apparatus and cassettes therefor, which are adapted to perform the method are also claimed.
    Type: Grant
    Filed: March 21, 2006
    Date of Patent: November 8, 2011
    Assignee: GE Healthcare Limited
    Inventors: Nigel John Osborn, Julian Grigg
  • Patent number: 7714115
    Abstract: The invention provides a method for the synthesis of an 18F-labelled product comprising deprotected of a protected 18F-labelled compound using a deprotection agent comprising a weak acid and wherein neutralisation and buffering of the deprotected product are carried out by the addition of a neutralisation agent. The deprotected product is buffered in a pH range suitable for subsequent autoclaving and formulation into an injectable radiopharmaceutical.
    Type: Grant
    Filed: September 23, 2005
    Date of Patent: May 11, 2010
    Assignee: GE Healthcare Limited
    Inventors: Julian Grigg, Nigel Osborn
  • Publication number: 20100029930
    Abstract: The present invention relates to a method for improving stability of non fluoridated sugar derivatives, and in particular glucose derivatives such as 1,3,4,6-tetra-O-acetyl-2-O-trifluoromethanesulfonyl-?-D-mannopyranose which are used as precursors for production of radiofluoridated sugar derivatives for use in in vivo imaging procedures such as positron emission tomography (PET). The method comprises storing the non fluoridated sugar derivative in an organic solvent. The resultant formulations of the non fluoridated sugar derivative and cassettes for automated synthesis apparatus comprising the same are also claimed.
    Type: Application
    Filed: November 18, 2005
    Publication date: February 4, 2010
    Inventors: Lill Torild Wickstrom, Dirk-Jan in't Veld, Nigel John Osborn, Julian Grigg, Anthony Wilson
  • Publication number: 20090076259
    Abstract: The invention relates to an improved process for the fluoridation of sugar derivatives in which a controlled amount of water is present in the solvent.
    Type: Application
    Filed: November 18, 2005
    Publication date: March 19, 2009
    Inventors: Nigel John Osborn, Julian Grigg, Roger Paul Pettitt, Anthony Wilson, Nigel Anthony Powell
  • Publication number: 20080226543
    Abstract: The invention describes a method for stripping alumina which is particularly suitable for removal of fluoride from alumina and comprises washing said alumina with an aqueous acid or alkali at elevated temperature. The method may be used for removal of unreacted radiofluoride such as [18F]fluoride from alumina following a radiofluorination reaction. Automated synthesis apparatus and cassettes therefor, which are adapted to perform the method are also claimed.
    Type: Application
    Filed: March 21, 2006
    Publication date: September 18, 2008
    Inventors: Nigel John Osborn, Julian Grigg
  • Publication number: 20080076914
    Abstract: The invention provides a method for the synthesis of an 18F-labelled product comprising deprotected of a protected 18F-labelled compound using a deprotection agent comprising a weak acid and wherein neutralisation and buffering of the deprotected product are carried out by the addition of a neutralisation agent. The deprotected product is buffered in a pH range suitable for subsequent autoclaving and formulation into an injectable radiopharmaceutical.
    Type: Application
    Filed: September 23, 2005
    Publication date: March 27, 2008
    Inventors: Julian Grigg, Nigel Osborn
  • Publication number: 20070131891
    Abstract: A fire or explosion suppression system comprises a source (30) of a liquid suppressant under pressure, and a source (32) of an inert gas under pressure. The liquid suppressant is a chemical substance having a low environmental impact, with a short atmospheric lifetime of less than 30 days. The inert gas may be nitrogen, carbon dioxide, argon, neon or helium or mixtures of any two or more of them. The suppressant and the inert gas are fed under pressure to an output unit (34) comprising a mixing chamber in which the liquid and the gas impinge to produce a mist of the liquid suppressant of very small droplet size which is entrained in the pressurised gas together with vapour from the liquid, the so-entrained mist and vapour and the gas being discharged by a nozzle (44) into an area to be protected. The mist and vapour are therefore carried by the entraining and transporting high pressure gas into regions of the areas to be protected, enabling a total flooding capability.
    Type: Application
    Filed: November 6, 2006
    Publication date: June 14, 2007
    Applicant: Kidde IP Holdings Limited
    Inventor: Julian Grigg
  • Patent number: 7153446
    Abstract: A fire or explosion suppression system comprises a source (30) of a liquid suppressant under pressure, and a source (32) of an inert gas under pressure. The liquid suppressant is a chemical substance having a low environmental impact, with a short atmospheric lifetime of less than 30 days. The inert gas may be nitrogen, carbon dioxide, argon, neon or helium or mixtures of any two or more of them. The suppressant and the inert gas are fed under pressure to an output unit (34) comprising a mixing chamber in which the liquid and the gas impinge to produce a mist of the liquid suppressant of very small droplet size which is entrained in the pressurised gas together with vapour from the liquid, the so-entrained mist and vapour and the gas being discharged by a nozzle (44) into an area to be protected. The mist and vapour are therefore carried by the entraining and transporting high pressure gas into regions of the areas to be protected, enabling a total flooding capability.
    Type: Grant
    Filed: March 28, 2002
    Date of Patent: December 26, 2006
    Assignee: Kidde IP Holdings Limited
    Inventor: Julian Grigg
  • Publication number: 20040163825
    Abstract: A fire and explosion suppression system comprises a source (5) of high pressure water which is fed to a misting nozzle (13) or other water mist generating means at one input of a mixing unit (6), and a source (14) of high pressure inert gas, such as nitrogen, which is fed along a pipe (20) to another input of the mixing unit (6). Inside the mixing unit (6), water mist, in the form of an atomised mist of very small droplet size is mixed with the pressurised gas and exits the mixing unit (6) at high pressure and high velocity along a pipe (22) and is thence discharged through spreaders (26, 28). Separation of the mist production from the actual discharge of the mist, and the entraining and transporting of the mist between these two stages at high pressure and high velocity, produces an output mist of very small droplet size which is carried by the entraining and transporting high pressure gas into the area to be protected, enabling a total flooding capability.
    Type: Application
    Filed: March 29, 2004
    Publication date: August 26, 2004
    Inventors: Robert George Dunster, Simon John Davies, Robert James Lade, Julian Grigg
  • Publication number: 20040144949
    Abstract: A fire or explosion suppression system comprises a source (30) of a liquid suppressant under pressure, and a source (32) of an inert gas under pressure. The liquid suppressant is a chemical substance having a low environmental impact, with a short atmospheric lifetime of less than 30 days. The inert gas may be nitrogen, carbon dioxide, argon, neon or helium or mixtures of any two or more of them. The suppressant and the inert gas are fed under pressure to an output unit (34) comprising a mixing chamber in which the liquid and the gas impinge to produce a mist of the liquid suppressant of very small droplet size which is entrained in the pressurised gas together with vapour from the liquid, the so-entrained mist and vapour and the gas being discharged by a nozzle (44) into an area to be protected. The mist and vapour are therefore carried by the entraining and transporting high pressure gas into regions of the areas to be protected, enabling a total flooding capability.
    Type: Application
    Filed: March 29, 2004
    Publication date: July 29, 2004
    Inventor: Julian Grigg